Tag: Prescription Drugs
Black Patients With Overactive Bladder Less Likely to Receive β3-Adrenoceptor Agonists
Higher likelihood of receiving an anticholinergic medication may contribute to other inequities
Dupilumab Reduces Exacerbations in Patients With COPD
Significant improvement also seen in lung function, quality of life, severity of COPD symptoms
Prenatal Valproate Exposure Tied to Psychiatric Disorders in Late Childhood
Risk by age 18 years was driven by disorders within the neurodevelopmental spectrum
Bleeding-Linked Hospitalization Up With Amiodarone in A-Fib
Risk up with amiodarone versus flecainide or sotalol among seniors with atrial fibrillation receiving apixaban or rivaroxaban
Sex Differences Seen in Cognitive Impairment for Tardive Dyskinesia in Schizophrenia
Protective effect suggested with female gender for schizophrenia patients with tardive dyskinesia
Medicare Spending Would Increase $2.0 to $5.1 Billion With Lecanemab
$2.0 to $5.1 billion would include lecanemab and ancillary costs; estimated annual per-patient coinsurance could reach $6,636
FDA Approves First Pill to Treat Moderate-to-Severe Crohn Disease
In clinical trials, more patients taking Rinvoq achieved remission and reduced intestinal inflammation compared with patients given a placebo
Allopurinol May Cut Risk for Neurodegenerative Diseases
Allopurinol linked to 13 to 34 percent lower risk for Parkinson disease, Alzheimer disease, ALS
One in Five Seniors Report Cost-Related Medication Nonadherence
Most respondents indicated a desire for use of a real-time benefit tool, with concern reported regarding inaccurate prices
Brepocitinib Beneficial for Moderate-to-Severe Psoriatic Arthritis
Significantly greater ACR20 response rates seen at week 16 for 30 and 60 mg QD versus placebo; response maintained or improved at 52 weeks
